According to a recent market study published by Growth Market Reports, titled, “Global Virus Biosensors Market by Biosensor Technology Type, By Application, By End-User, and By Region: Size, Share, Trends and Opportunity Analysis, 2016-2031”, the market was valued at US$ 148.49 Million in 2022 and is anticipated to expand at a growth rate of 6.6% by 2031.

Get Sample Report @ https://growthmarketreports.com/request-sample/6207

Virus biosensors are analytical devices that can detect the presence of viruses in a sample. These biosensors utilize various sensing technologies, such as optical, electrical, or mechanical, to provide rapid and accurate results. They are essential tools for virus diagnosis, monitoring, and prevention in various applications, including clinical diagnostics, environmental monitoring, and biodefense. The sensing mechanism of virus biosensors involves the specific recognition and binding of viruses to their corresponding receptors or antibodies immobilized on the sensor surface. This interaction generates a measurable signal that can be quantified and interpreted by the sensor's electronics. The signal can be in the form of a change in electrical conductivity, light emission, or mechanical deformation, depending on the sensor's design.

The advantages of virus biosensors over traditional methods of virus detection include faster response times, higher sensitivity and specificity, and reduced sample volume requirements. They also offer the potential for point-of-care diagnostics and real-time monitoring of viral outbreaks. However, some challenges still need to be addressed, such as the need for reliable and stable sensor materials, the development of multiplexed sensors for simultaneous detection of multiple viruses, and the integration of sensors into wearable devices for continuous monitoring.

The global virus biosensors market has been segmented in terms of biosensor technology type, application, end-user. In terms of biosensor technology type, the global virus biosensors market is segregated into electrochemical biosensors, thermometric biosensors, optical biosensors, enzyme biosensor, DNA biosensor, and others. On the basis of application, the market is fragmented into point-of-care testing (POCT), research laboratory, home diagnostics, environmental testing, biodefence, others. Based on end-user, the market is segregated into clinical diagnostic laboratories, hospitals, research laboratories, and others. Considering regions, the market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

The COVID-19 pandemic has had a significant impact on the virus biosensors market, the pandemic has accelerated the adoption and advancement of biosensors for the diagnosis of COVID-19 and other viruses, leading to the development of innovative and efficient virus detection techniques, including optical biosensors and carbon nanoparticle-based COVID-19 biosensors. The virus biosensor market has experienced significant growth and innovation in response to the urgent need for effective and rapid virus detection technologies during the COVID-19 pandemic.

Key Takeaways from the Study:

  • Players in the global virus biosensors market include Creative Biolabs., CANATU, Conductive Technologies, Menon Biosensors Inc., PalmSens, Sartorius AG, Zimmer and Peacock.

  • Based on biosensor technology type, the global virus biosensors market is segmented into electrochemical biosensors, thermometric biosensors, optical biosensors, enzyme biosensor, DNA biosensor, and others.

  • The electrochemical segment held a notable market share in 2022 and is projected to expand at a CAGR of xx% during the forecast period. Electrochemical biosensors can detect viruses at very low concentrations, making them highly sensitive. Additionally, it can differentiate between different viruses due to their specific binding to antibodies or receptors, providing high selectivity.

  • Based on application, the global virus biosensors market is segregated into point-of-care testing (POCT), research laboratory, home diagnostics, environmental testing, biodefence, others. The Point-Of-Care Testing (POCT) segment accounted for xx% share of the market in 2022 and is projected to expand at a notable CAGR during the forecast period. POCT enables for speedier detection and treatment of diseases and medical disorders because test results are typically accessible within minutes or hours. This is especially critical in emergency settings, where fast diagnosis and treatment can make the difference between life and death.

  • Based on end-user, the global virus biosensors market is segregated into clinical diagnostic laboratories, hospitals, research laboratories, and others. The hospitals segment is projected to expand at a CAGR of XX% during the forecast period. As the COVID-19 pandemic shown, viral outbreaks resulted in a significant increase in demand for testing; thus, hospitals equipped with viral biosensors may be better adapted to meet this demand since they are able to provide faster and more reliable test results than traditional laboratory facilities. The increased demand for testing may result in more revenue for hospitals.

  • Based on regions, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in Europe accounted for a XX% share of the market in 2022 owing to the escalating demand for biosensors in diagnostics, point-of-care testing, and the increasing use in the process of drug discovery.

  • Europe has witnessed an increase in the prevalence of lifestyle diseases and a rise in the elderly population which is contributing to market growth. Countries such as Germany, UK, and France are the leading in this market due to their highly developed healthcare systems which leads to the surge in virus testing demand and the presence of major market players.

Key Developments

  • In June 2023, GrapheneDx, General Graphene, and Sapphiros had formed a strategic cooperation to develop and commercialize graphene-based biosensors for diagnostic medical devices.

Report Scope:

Report Metric

Details

Market Value in 2022

US$ 148.49 Million

Market Growth Rate (from 2022 to 2031)

6.6%

Historical Data

2016 & 2021

Base Year

2022

Forecast Period

2023 – 2031

Units Considered

Value (US$ Million)

Market Segments

By Biosensor Technology Type, By Application, By End-user, and By Region

Key Companies Profiled

Creative Biolabs., CANATU, Conductive Technologies, Menon Biosensors Inc., PalmSens, Sartorius AG, Zimmer and Peacock.

Customization Scope

Report customization available on request

Pricing and Purchase Options

Avail of tailor-made purchase options to meet your research requirements.

 

Target Audience:

  • Supply-side: Manufacturers, Suppliers/Distributors and Logistics, End-users/Applications

  • Regulatory Side: Concerned government authorities, and other approved regulatory bodies.

      • United States Food and Drug Administration (FDA)

      • European Union (EU) Medical Devices Directive (MDD)

      • Brazil National Health Surveillance Agency (ANVISA)

      • Israel Ministry of Health (MOH), etc.